Bach, Jean-François

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine

Diabetes and associated disordersDiabetes Management and Research

Cited by 1,099

Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients

Joutel, A., Vahedi, K., Corpechot, C., Troesch, A., Chabriat, H., Vayssière, C., Cruaud, C., Maciazek, J., Weissenbach, J., Bousser, M.-G., et al. (1997) · The Lancet

Cerebrovascular and genetic disordersGenetic Neurodegenerative Diseases

Cited by 682

CYCLOSPORIN INCREASES THE RATE AND LENGTH OF REMISSIONS IN INSULIN-DEPENDENT DIABETES OF RECENT ONSET

Feutren, G., Assan, R., Karsenty, G., Du Rostu, H., Sirmai, J., Papoz, L., Vialettes, B., Vexiau, P., Rodier, M., Lallemand, A., et al. (1986) · The Lancet

Diabetes and associated disordersDiabetes Management and Research

Cited by 448

Serum thymulin in human zinc deficiency

Prasad, A. S., Meftah, S., Abdallah, J., Kaplan, J., Brewer, G. J., Bach, J. F., & Dardenne, M. (1988) · Journal of Clinical Investigation

Trace Elements in HealthIron Metabolism and Disorders

Cited by 335

Anti-CD3 antibodies for type 1 diabetes: beyond expectations

Bach, J.-F. (2011) · The Lancet

Diabetes and associated disordersDiabetes Management and Research

Cited by 59

A historical view from thirty eventful years of immunotherapy in autoimmune diabetes

Bach, J.-F., & Chatenoud, L. (2011) · Seminars in Immunology

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 41